Colomer R - Search Results

1

Trastuzumab plus tamoxifen: anti-proliferative and molecular interactions in breast carcinoma.

Ropero S, Menéndez JA, Vázquez-Martín A, Montero S, Cortés-Funes H, Colomer R. Ropero S, et al. Among authors: colomer r. Breast Cancer Res Treat. 2004 Jul;86(2):125-37. doi: 10.1023/b:brea.0000032981.20384.c6. Breast Cancer Res Treat. 2004. PMID: 15319565

2

Circulating CA 15-3 levels in the postsurgical follow-up of breast cancer patients and in non-malignant diseases.

Colomer R, Ruibal A, Genollá J, Rubio D, Del Campo JM, Bodi R, Salvador L. Colomer R, et al. Breast Cancer Res Treat. 1989 Mar;13(2):123-33. doi: 10.1007/BF01806524. Breast Cancer Res Treat. 1989. PMID: 2730960

3

Circulating tumor marker levels in advanced breast carcinoma correlate with the extent of metastatic disease.

Colomer R, Ruibal A, Salvador L. Colomer R, et al. Cancer. 1989 Oct 15;64(8):1674-81. doi: 10.1002/1097-0142(19891015)64:8<1674::aid-cncr2820640820>3.0.co;2-v. Cancer. 1989. PMID: 2790682

4

Brain metastases from breast cancer may respond to endocrine therapy.

Colomer R, Cosos D, Del Campo JM, Boada M, Rubio D, Salvador L. Colomer R, et al. Breast Cancer Res Treat. 1988 Sep;12(1):83-6. doi: 10.1007/BF01805745. Breast Cancer Res Treat. 1988. PMID: 3196890 No abstract available.

5

erbB-2 antisense oligonucleotides inhibit the proliferation of breast carcinoma cells with erbB-2 oncogene amplification.

Colomer R, Lupu R, Bacus SS, Gelmann EP. Colomer R, et al. Br J Cancer. 1994 Nov;70(5):819-25. doi: 10.1038/bjc.1994.405. Br J Cancer. 1994. PMID: 7947086 Free PMC article.

6

A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary results.

Hitt R, Hornedo J, Colomer R, Mendiola C, Brandariz A, Sevilla E, Alvarez-Vicent J, Cortés-Funes H. Hitt R, et al. Among authors: colomer r. Semin Oncol. 1995 Dec;22(6 Suppl 15):50-4. Semin Oncol. 1995. PMID: 8643971 Clinical Trial.

7

Study of escalating doses of paclitaxel plus cisplatin in patients with inoperable head and neck cancer.

Hitt R, Hornedo J, Colomer R, Hidalgo M, Brandariz A, Peña M, Vicent JA, Cortés-Funes H. Hitt R, et al. Among authors: colomer r. Semin Oncol. 1997 Feb;24(1 Suppl 2):S2-58-S2-64. Semin Oncol. 1997. PMID: 9045339 Clinical Trial.

8

Patient selection in high-dose chemotherapy trials: relevance in high-risk breast cancer.

García-Carbonero R, Hidalgo M, Paz-Ares L, Calzas J, Gómez H, Guerra JA, Hitt R, Hornedo J, Colomer R, Cortés-Funes H. García-Carbonero R, et al. Among authors: colomer r. J Clin Oncol. 1997 Oct;15(10):3178-84. doi: 10.1200/JCO.1997.15.10.3178. J Clin Oncol. 1997. PMID: 9336353

9

Low levels of basic fibroblast growth factor (bFGF) are associated with a poor prognosis in human breast carcinoma.

Colomer R, Aparicio J, Montero S, Guzmán C, Larrodera L, Cortés-Funes H. Colomer R, et al. Br J Cancer. 1997;76(9):1215-20. doi: 10.1038/bjc.1997.536. Br J Cancer. 1997. PMID: 9365172 Free PMC article.

10

Phase I/II study of paclitaxel/cisplatin as first-line therapy for locally advanced head and neck cancer.

Hitt R, Paz-Ares L, Hidalgo M, Colomer R, Brandariz A, Peña M, Alvarez-Vicent J, Hornedo J, Cortés-Funes H. Hitt R, et al. Among authors: colomer r. Semin Oncol. 1997 Dec;24(6 Suppl 19):S19-20-S19-24. Semin Oncol. 1997. PMID: 9427260 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

211 results

Search Page

Filters